Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

CMMB holding history

Chemomab Therapeutics Ltd. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CMMB overviewAll 13F holders of CMMBFull Q2 2026 holdings

Shares (Q2 2026)
3,575
Value
$5.79K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of CMMB by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,575$5.79K<0.1%−1,000−21.9%ReducedHolders
Q1 20264,575$7.18K<0.1%+800+21.2%AddedHolders
Q4 20253,775$6.23K<0.1%−86,290−95.8%ReducedHolders
Q3 202590,065$236.9K<0.1%−313,469−77.7%ReducedConverted for a 1-for-4 splitHolders
Q2 20251,614,134$1.87M<0.1%+1,496,974+1,277.7%AddedHolders
Q1 2025117,160$127.7K<0.1%+12,760+12.2%AddedHolders
Q4 2024104,400$189.0K<0.1%−297,872−74.0%ReducedHolders
Q3 2024402,272$631.6K<0.1%+395,072+5,487.1%AddedHolders
Q2 20247,200$6.57K<0.1%+4,403+157.4%AddedHolders
Q1 20242,797$2.18K<0.1%−68,118−96.1%ReducedHolders
Q4 202370,915$36.2K<0.1%+70,915NewHolders
Q3 20230$00.0%−100−100.0%Sold outHolders
Q2 2023100$132<0.1%−7,700−98.7%ReducedHolders
Q1 20237,800$12.4K<0.1%+1,200+18.2%AddedHolders
Q4 20226,600$21.1K<0.1%+400+6.5%AddedHolders
Q3 20226,200$15.0K<0.1%+605+10.8%AddedHolders
Q2 20225,595$21.0K<0.1%+5,595NewHolders
Q1 20220$00.0%−11,643−100.0%Sold outHolders
Q4 202111,643$80.0K<0.1%+11,548+12,155.8%AddedHolders
Q3 202195$1.00K<0.1%−68−41.7%ReducedHolders
Q2 2021163$3.00K<0.1%−171−51.2%ReducedHolders
Q1 2021334$10.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.